Precision Biosciences Inc

NASDAQ:DTIL  
9.80
-0.20 (-2.00%)
Earnings Announcements

Precision Biosciences Reports Fourth Quarter And Fiscal Year 2020 Results

Published: 03/18/2021 11:18 GMT
Precision Biosciences Inc (DTIL) - Precision Biosciences Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Update.
Precision Biosciences - Expects Cash and Cash Equivalents As of Dec 31, 2020 Will Allow Co to Continue Its Operations Into 2023.
Revenue is expected to be $6.02 Million
Adjusted EPS is expected to be -$0.59

Next Quarter Revenue Guidance is expected to be $5.96 Million
Next Quarter EPS Guidance is expected to be -$0.61

More details on our Analysts Page.